Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Klingman Associates LLC Increases Position in AbbVie Inc. ABBV

November 10, 2024
Klingman Associates LLC, a notable investment firm, recently increased its position in AbbVie Inc. (NYSE:ABBV). With this move, the company shows confidence in the future prospects of AbbVie, a leading pharmaceutical company. AbbVie has been making significant advancements in the healthcare sector, particularly in the development of innovative treatments for various diseases. This increased stake by Klingman Associates LLC highlights the potential growth and profitability of AbbVie, attracting the attention of many investors. For a professional analysis and forecast of AbbVie's stock movement, it is recommended to consult Stocks Prognosis, a trusted source for market insights.
If you want to leave a comment, then you need Login or Register





Other data for ABBV

Related data

ABBVSeptember 11, 2025ABBVIE INC. Stock Hits Forecast Price Target with 12.81% Profit as Predicted by QuantWave  ~1 min.

On August 1, 2025, QuantWave, an automated forecasting platform, issued a long signal for ABBVIE INC. stock when it was trading at 195.22 $....


ABBVSeptember 2, 2025ABBVIE INC. Hits Price Target Forecast Profit of 11.94% on QuantWave  ~1 min.

On July 30, 2025, QuantWave, the automated forecasting platform, issued a long signal for ABBVIE INC. stock when it was trading at 189.31 $....


ABBVAugust 20, 2025ABBVIE INC. Hits Forecast Price Target with 10.4% Profit: A Success Story for QuantWave  ~1 min.

On June 13, 2025, QuantWave issued a long signal for ABBVIE INC. when the stock was trading at 189.44 $. Fast forward to August 20, 2025, and the forecasted price target of 209....


ABBVMarch 22, 2025AbbVie ABBV Stock Moves -0.29: What You Should Know  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, has recently experienced a slight decrease in stock movement. As an investor, it is essential to keep track of such fluctuations....


ABBVMarch 20, 2025AbbVie Inc. ABBV is Experiencing Global Investor Interest: A Look into the Company's Success Story  ~2 min.

AbbVie Inc., a renowned pharmaceutical company, has been making waves in the global market, attracting significant attention from investors worldwide....


ABBVMarch 19, 2025AbbVie Inc. ABBV: A Higher-Yielding Healthcare Play That Continues to Shine  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, is steadily gaining the attention of investors. With its continuous success in the healthcare industry, AbbVie has become a top choice for hedge funds....


ABBVMarch 18, 2025The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell, and Hamilton Beach Brands  ~1 min.

According to a recent analysis by Zacks, AbbVie Inc. (ABBV) is considered one of the top healthcare stocks to invest in....


ABBVMarch 14, 2025AbbVie Inc. ABBV is Attracting Investor Attention: Here is What You Should Know  ~2 min.

AbbVie Inc. (ABBV) has been grabbing the attention of investors recently with its impressive performance in the healthcare sector....


ABBVMarch 10, 2025ABBVIE INC. Hits Price Target Forecast with 15.28% Profit – A Triumph for QuantWave's Analytics  ~1 min.

ABBVIE INC. achieved a significant milestone as it hit the price target forecast set by QuantWave, resulting in a profit of 15.28%....


ABBVMarch 10, 2025ABBVIE INC. Hits Price Target Forecast on QuantWave with 15.28% Profit Margin  ~1 min.

AbbVie Inc. (ABBV) has successfully reached the price target forecast on QuantWave, signaling a profitable long position for investors. The forecast, initiated on August 13, 2024, at a price of $184....


VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....


VRTXFebruary 3, 2025Vertex Pharmaceuticals Incorporated VRTX to Unveil Q4 2024 Financial Results on February 10  ~2 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has announced that it will be revealing its fourth quarter and full-year 2024 financial results on February 10....


ABBVOctober 30, 2024Should AbbVie Stock Be in Your Portfolio Pre-Q3 Earnings?  ~2 min.

AbbVie Inc. (NYSE:ABBV) is set to release its third-quarter earnings report soon, and investors are eagerly anticipating the results....


GSKJanuary 15, 2025GSK Acquires IDRx for 1B Gaining Breakthrough GIST Cancer Drug  ~2 min.

GSK PLC, a leading pharmaceutical company, has recently announced its acquisition of IDRx, a US-based biotech business, for a staggering amount of 1 billion dollars....


ABBVJanuary 9, 2025AbbVie Inc. NYSE:ABBV Captivates Institutional Shareholders with 73% Ownership  ~2 min.

AbbVie Inc., the renowned pharmaceutical company listed on NYSE under the ticker symbol ABBV, boasts an impressive 73% ownership by institutional shareholders....